Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Inmyung Yang"'
Autor:
Seungjoon Park, Inmyung Yang, Sung-Woon Kim, Jinwoo Kim, Cheol-Young Park, Jeong Taek Woo, Young-Seol Kim
Publikováno v:
European Journal of Endocrinology. :635-640
OBJECTIVE: Acute hyperglycemia stimulates somatostatin (SRIH) release by the hypothalamus which, in turn, suppresses growth hormone (GH) secretion from the anterior pituitary gland. Although it has been suggested that the cholinergic pathway mediates
Autor:
David W. Ellison, Brian Harding, Xiaoguang Fan, M. Beatriz S. Lopes, Jairam R. Eswara, Inmyung Yang, Rajesh V. Thakker, Michael A. Levine, Roberto Salvatori, P. D. Lees
Publikováno v:
Clinical Endocrinology. 54:301-307
GH-releasing hormone (GHRH) is a potent stimulator of somatotroph cell proliferation and GH secretion. GHRH acts via binding to a G-protein coupled receptor (GPCR) (GHRH-R), that activates adenylyl cyclase (AC) and increases growth and function of so
Autor:
Rin Chang, Byung-Ho Kim, Kyeong-Jin Kim, Yo-Seb Han, Seok-Ho Dong, Joung-Il Lee, Hee-Jin Kim, Young-Woon Chang, Inmyung Yang, Hyo-Jong Kim
Publikováno v:
The American Journal of Gastroenterology. 96:165-169
Although symptomatic propylthiouracil (PTU)-induced hepatic injury is known to be rare, there have been few reports about its exact incidence in patients with hyperthyroidism. We tried to evaluate its incidence in a single center and its clinical cou
Autor:
Yun Min Kim, Sun Jin Park, Y.Y. Choi, Sung-Woon Kim, Jeong Taek Woo, Inmyung Yang, Jung Sup Kim
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:2492-2496
Oral glucose administration suppresses the TRH-induced TSH response by enhancing the hypothalamic somatostatinergic activity (HSA). We assessed the HSA in 13 acromegalic patients by measuring glucose-induced suppression of TRH-stimulated TSH secretio
Publikováno v:
Hormone and Metabolic Research. 28:553-557
To determine whether the combined glucose-thyrotropin-releasing hormone (TRH) test can be a useful method for the evaluation of the hypothalamic somatostatinergic activity, we investigated whether TRH-induced thyroid stimulating hormone (TSH) secreti
Publikováno v:
European Journal of Endocrinology. 133:457-462
Yang I, Woo J, Kim S, Kim J, Kim Y, Choi Y. Combined pyridostigmine–thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men. Eur J Endocrinol 1995;133:457–62. ISSN 0804–4643 Pyrido
Autor:
Inmyung Yang, Seungjoon Oh, Sung Woo Park, Young-Seol Kim, Gwanpyo Koh, Jinwoo Kim, Cheol-Young Park, Jeong Taek Woo, Seungjoon Park, Sung-Woon Kim, Sookjin Sohn, Ki-Won Oh, Eunhee Kim
Publikováno v:
Endocrine journal. 52(1)
Thyrotropin-releasing hormone (TRH)-stimulated thyroid stimulating hormone (TSH) response in normal subjects is suppressed by oral glucose administration. Pharmacologic studies indicate that this suppressive action of glucose is mediated by an increa
Autor:
Heesoon Park, Jee-Chang Jung, Sookjin Sohn, Eunhee Kim, Cheol-Young Park, Inmyung Yang, Jeong Taek Woo, Jinwoo Kim, Young-Seol Kim, Mina Lee, Seungjoon Park, Sung-Woon Kim
Publikováno v:
Endocrine journal. 51(2)
To investigate the potential pathophysiologic role of human SRIF receptor gene expression in GH-secreting adenomas in acromegalic patients, we studied the relationship between the SRIF receptor gene expression, endogenous SRIF activity and exogenous
Autor:
Young-Kil Choi, Mee-Sook Ryu, Jinwoo Kim, Inmyung Yang, Seungjoon Park, Sung-Woon Kim, Jeong Taek Woo, Young-Seol Kim
Publikováno v:
European journal of endocrinology. 134(6)
Yang I, Park S, Ryu M, Woo J, Kim S, Kim J, Kim Y, Choi Y. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Eur J Endocrinol 1996;134: 720–6. ISSN 0804–4643 A subset of human growth hormone
Publikováno v:
Clinical endocrinology. 42(3)
Background and objectives In GH-secreting pituitary tumours somatostatin receptor density has been correlated with octreotide responsiveness. Little is known about the other endocrine characteristics of patients with good responses to octreotide. The